RecruitingPhase 2Phase 3NCT06567821

Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy

Sponsor

Cedars-Sinai Medical Center

Enrollment

50 participants

Start Date

Sep 4, 2024

Study Type

INTERVENTIONAL

Conditions

Chronic Maxillary Rhinosinusitis

Summary

The purpose of the research is to examine the effectiveness of navigation in maxillary sinus balloon dilation for the treatment of chronic maxillary rhinosinusitis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called RELIEVA SPINPLUS® NAV Balloon Sinusplasty System for people with chronic maxillary rhinosinusitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERELIEVA SPINPLUS® NAV Balloon Sinusplasty System

The non-navigated device being used is the RELIEVA SPINPLUS® Balloon Sinusplasty System and the navigated device being used is the RELIEVA SPINPLUS® NAV Balloon Sinusplasty System. Both devices being used are standard devices that are currently FDA approved and used in practice for sinus dilation at Cedars-Sinai Medical Center.

Locations(1)

Cedars Sinai

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06567821